GCDPipe: risk gene, cell type, and drug ranking for complex traits
preprint
OA: closed
AI-generated summary
This paper introduces GCDPipe, a novel computational method for ranking genes, cell types, and drugs associated with complex traits by integrating genetic and cellular data.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
We introduce a user-friendly machine learning tool for risk gene, cell type, and drug ranking for complex traits - GCDPipe. It uses gene-level GWAS-derived data and publicly available expression data to train a model for prediction of disease risk genes and relevant cell types. Gene-ranking information is then coupled with known drug targets data to prioritize drugs based on their estimated functional effects associated with identified risk genes. The pipeline was tested in two case studies: inflammatory bowel disease (IBD) and schizophrenia, then it was applied to Alzheimer’s disease to investigate potential options for drug repurposing. The results show that GCDPipe is an effective tool to unify genetic risk factors with cellular context and known drug targets.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00